Floatz logo

QUINIDINE SULFATE HYDRATE

Pseudobulbar Affect (PBA)

Avanir PharmaceuticalsSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Pseudobulbar Affect (PBA) cohort.

Asset / SponsorPhaseRating
Dextromethorphan
Avanir Pharmaceuticals
Phase 4BBB

Same molecule, other indications

QUINIDINE SULFATE HYDRATE is also rated in:

depressive disorderDormant
B
Indicative ·
57 / 100
View asset →
amyotrophic lateral sclerosisDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →